City Therapeutics
A biopharmaceutical company developing RNA interference (RNAi)-based medicines.
About
City Therapeutics is a biopharmaceutical company focused on advancing the field of RNA interference (RNAi)-based medicine. They are developing novel therapeutic approaches utilizing RNAi technology.
Key facts
At-a-glance profile data
- Website
- citytherapeutics.com
- Headquarters
- Cambridge, Massachusetts, USA
- Founded
- 2019
- Total funding
- $100M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 8 Jun 2026 | Series B | $100M | - |
Tech stack
Detected on citytherapeutics.com, last scanned 18 Sept 2026. Run your own scan
- Compliance
- GDPR, CCPA
- CDN
- Cloudflare
- Email provider
- Microsoft 365
“Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies.”
View on Reddit“BIIB | Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies.”
View on Reddit“It seems the tides are turning from a Biotech perspective. Three IPOs raised $900 million, and City Therapeutics and Judo Therapeutics launched.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has City Therapeutics raised?
City Therapeutics has raised a total of $100M in funding. The most recent round on record is Series B.